Tectonic Therapeutics TECX Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Tectonic Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tectonic Therapeutics's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tectonic Therapeutics's stock-based comp?
- Tectonic Therapeutics (TECX) reported stock-based comp of $3.21M in Q1 2026.
- How has Tectonic Therapeutics's stock-based comp changed year-over-year?
- Tectonic Therapeutics's stock-based comp increased by 52.4% year-over-year, from $2.1M to $3.21M.
- What is the long-term trend for Tectonic Therapeutics's stock-based comp?
- Over 3 years (2021 to 2025), Tectonic Therapeutics's stock-based comp has grown at a -17.3% compound annual growth rate (CAGR), from $18.58M to $10.5M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.